Evofem Biosciences Inc (OTCPK:EVFM)
$ 0.0145 -0.0015 (-9.38%) Market Cap: 900,000.00 Enterprise Value: 43.41 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Evofem Biosciences Inc at ROTH Conference - Fireside Chat Transcript

Mar 19, 2019 / 09:00PM GMT
Release Date Price: $6768.72 (-1.37%)
Yasmeen Rahimi
ROTH Capital Partners - Analyst

Good afternoon my name is Yasmeen Rahimi; I am a senior research analyst here at ROTH Capital Partners in the biotech sector. Thank you; it's really a pleasure to have Kelly Culwell, Chief Medical Officer of Evofem Biosciences. Thank you so much for being here and the format of this particular discussion is fireside chat. Feel free to interrupt us with questions.

So Kelly, thank you for being here. Can you walk us through what is your lead asset? What indication are you pursuing it for and where are you in your development stage?

Kelly Culwell
Evofem Biosciences, Inc. - Chief Medical Officer

Great, thank you. It's a pleasure to be here. Thanks very much for the invitation. So as Yasmeen mentioned, I am with Evofem Biosciences and our lead asset is called Amphora. It's a multipurpose vaginal pH regulator, or MVPR for short. And our primary indication is contraception, so prevention of pregnancy in women.

We have completed our Phase 3 trial and we are in the process of compiling our NDA

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot